Abiopharma

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

Bruker - Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Press Release: AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Reports Second Quarter 2026 Results

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Lincoln National Corporation’s Board of Directors Declares Quarterly Cash Dividend & Announces Plans to Resume Share Repurchases in the Third Quarter of 2026

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

TCIM Comments on Voya’s Efforts to Prevent Shareholder Voices from Being Heard

Palladyne AI Appoints Former MARSOC Commander and U.S. Special Operations Command Chief of Staff Maj. Gen. Mark A. "Droopy" Clark (Ret.) to Defense Advisory Board

Western Midstream Announces Second-Quarter Post-Earnings Interview with Chief Financial Officer, Kristen Shults and Participation in Upcoming Investor Conferences